×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
NYSE:ELAN

Elanco Animal Health Stock Forecast, Price & News

$20.61
+0.67 (+3.36%)
(As of 06/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$20.15
$20.96
50-Day Range
$19.94
$26.28
52-Week Range
$19.56
$37.49
Volume
5.53 million shs
Average Volume
4.76 million shs
Market Capitalization
$9.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$34.60
30 days | 90 days | 365 days | Advanced Chart

Receive ELAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter.

ELAN Stock Forecast (MarketRank)

Overall MarketRank

2.29 out of 5 stars

Medical Sector

280th out of 1,418 stocks

Pharmaceutical Preparations Industry

112th out of 679 stocks

Analyst Opinion: 3.3Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -
Elanco Animal Health logo

About Elanco Animal Health (NYSE:ELAN)

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

ELAN Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
1,100
Year Founded
N/A

Company Calendar

Last Earnings
5/09/2022
Today
6/24/2022
Next Earnings (Estimated)
8/08/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$32.20
High Stock Price Forecast
$38.00
Low Stock Price Forecast
$22.00
Forecasted Upside/Downside
+67.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.6
Research Coverage
5 Analysts

Profitability

Net Income
$-472 million
Pretax Margin
-8.76%

Debt

Sales & Book Value

Annual Sales
$4.77 billion
Cash Flow
$2.68 per share
Book Value
$15.93 per share

Miscellaneous

Free Float
443,754,000
Market Cap
$9.77 billion
Optionable
Optionable
Beta
0.74














Elanco Animal Health Frequently Asked Questions

Should I buy or sell Elanco Animal Health stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Elanco Animal Health in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" Elanco Animal Health stock.
View analyst ratings for Elanco Animal Health
or view top-rated stocks.

What is Elanco Animal Health's stock price forecast for 2022?

5 Wall Street analysts have issued 1-year price objectives for Elanco Animal Health's stock. Their ELAN stock forecasts range from $22.00 to $38.00. On average, they expect Elanco Animal Health's stock price to reach $32.20 in the next twelve months. This suggests a possible upside of 56.2% from the stock's current price.
View analysts' price targets for Elanco Animal Health
or view top-rated stocks among Wall Street analysts.

How has Elanco Animal Health's stock price performed in 2022?

Elanco Animal Health's stock was trading at $28.38 on January 1st, 2022. Since then, ELAN stock has decreased by 27.4% and is now trading at $20.61.
View the best growth stocks for 2022 here
.

When is Elanco Animal Health's next earnings date?

Elanco Animal Health is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Elanco Animal Health
.

How were Elanco Animal Health's earnings last quarter?

Elanco Animal Health Incorporated (NYSE:ELAN) posted its quarterly earnings results on Monday, May, 9th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.01. The company earned $1.23 billion during the quarter, compared to analysts' expectations of $1.22 billion. Elanco Animal Health had a negative net margin of 7.65% and a positive trailing twelve-month return on equity of 6.61%. The firm's revenue was down 1.4% on a year-over-year basis. During the same period last year, the company posted $0.37 EPS.
View Elanco Animal Health's earnings history
.

What guidance has Elanco Animal Health issued on next quarter's earnings?

Elanco Animal Health issued an update on its second quarter 2022 earnings guidance on Monday, June, 6th. The company provided earnings per share (EPS) guidance of $0.22-$0.28 for the period, compared to the consensus EPS estimate of $0.34. The company issued revenue guidance of $1.16 billion-$1.20 billion, compared to the consensus revenue estimate of $1.27 billion.

Who are Elanco Animal Health's key executives?

Elanco Animal Health's management team includes the following people:
  • Mr. Jeffrey N. Simmons, Pres, CEO & Director (Age 55, Pay $2.8M) (LinkedIn Profile)
  • Mr. Todd S. Young, Exec. VP of Corp. Governance and Strategy & CFO (Age 50, Pay $1.18M) (LinkedIn Profile)
  • Mr. Ramiro Martin Cabral, Exec. VP & Pres of Elanco International (Age 50, Pay $941.11k)
  • Mr. James M. Meer, Sr. VP & Chief Accounting Officer (Age 52)
  • Mr. Chris Keeley, Sr. VP & Chief Information Officer
  • Mr. David S. Kinard, Exec. VP of HR Corp. Affairs & Admin. (Age 55)
  • Ms. Marcela A. Kirberger, Exec. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Mr. David Alan Urbanek, Exec. VP of Manufacturing & Quality (Age 55)
  • Mr. Shawn McKee, Sr. VP of U.S. Companion Animal
  • Mr. Larbi Van Lier, Sr. VP of Asia

What is Jeff Simmons' approval rating as Elanco Animal Health's CEO?

169 employees have rated Elanco Animal Health CEO Jeff Simmons on Glassdoor.com. Jeff Simmons has an approval rating of 89% among Elanco Animal Health's employees.

What other stocks do shareholders of Elanco Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Elanco Animal Health investors own include NVIDIA (NVDA), AbbVie (ABBV), Micron Technology (MU), QUALCOMM (QCOM), Walt Disney (DIS), Johnson & Johnson (JNJ), AT&T (T), Cisco Systems (CSCO), CVS Health (CVS) and Bristol-Myers Squibb (BMY).

When did Elanco Animal Health IPO?

(ELAN) raised $1.4 billion in an initial public offering on Thursday, September 20th 2018. The company issued 62,900,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

What is Elanco Animal Health's stock symbol?

Elanco Animal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELAN."

Who are Elanco Animal Health's major shareholders?

Elanco Animal Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.74%), Primecap Management Co. CA (6.51%), BlackRock Inc. (5.54%), State Street Corp (2.65%), Goldman Sachs Group Inc. (2.55%) and Vantage Investment Partners LLC (1.46%). Company insiders that own Elanco Animal Health stock include Aktiengesellschaft Bayer, Art A Garcia, David Alan Urbanek, Dawei Li, Deborah Turner Kochevar, Elanco Animal Health Inc, Jeffrey N Simmons, John P Bilbrey, Michael J Harrington, Michael-Bryant Hicks, R David Hoover and Todd S Young.
View institutional ownership trends for Elanco Animal Health
.

Which major investors are selling Elanco Animal Health stock?

ELAN stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Robeco Institutional Asset Management B.V., Soros Fund Management LLC, Aviva PLC, Group One Trading L.P., Royal Bank of Canada, Raymond James & Associates, and Starboard Value LP.
View insider buying and selling activity for Elanco Animal Health
or view top insider-selling stocks.

Which major investors are buying Elanco Animal Health stock?

ELAN stock was acquired by a variety of institutional investors in the last quarter, including Ontario Teachers Pension Plan Board, BlackRock Inc., Goldman Sachs Group Inc., Sound Shore Management Inc. CT, Sculptor Capital LP, Sculptor Capital LP, The Manufacturers Life Insurance Company , and Dimensional Fund Advisors LP. Company insiders that have bought Elanco Animal Health stock in the last two years include Art A Garcia, Elanco Animal Health Inc, Jeffrey N Simmons, John P Bilbrey, Michael J Harrington, R David Hoover, and Todd S Young.
View insider buying and selling activity for Elanco Animal Health
or or view top insider-buying stocks.

How do I buy shares of Elanco Animal Health?

Shares of ELAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Elanco Animal Health's stock price today?

One share of ELAN stock can currently be purchased for approximately $20.61.

How much money does Elanco Animal Health make?

Elanco Animal Health (NYSE:ELAN) has a market capitalization of $9.77 billion and generates $4.77 billion in revenue each year. The company earns $-472 million in net income (profit) each year or ($0.740010) on an earnings per share basis.

How many employees does Elanco Animal Health have?

Elanco Animal Health employs 1,100 workers across the globe.

How can I contact Elanco Animal Health?

Elanco Animal Health's mailing address is 2500 INNOVATION WAY, GREENFIELD IN, 46140. The official website for Elanco Animal Health is www.elanco.com. The company can be reached via phone at (877) 352-6261 or via email at [email protected].

This page (NYSE:ELAN) was last updated on 6/25/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.